Cargando…
Nanoparticles for transcutaneous vaccination
The living epidermis and dermis are rich in antigen presenting cells (APCs). Their activation can elicit a strong humoral and cellular immune response as well as mucosal immunity. Therefore, the skin is a very attractive site for vaccination, and an intradermal application of antigen may be much mor...
Autores principales: | Hansen, Steffi, Lehr, Claus‐Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815776/ https://www.ncbi.nlm.nih.gov/pubmed/21854553 http://dx.doi.org/10.1111/j.1751-7915.2011.00284.x |
Ejemplares similares
-
Vaccine development against Neisseria meningitidis
por: Vogel, Ulrich, et al.
Publicado: (2011) -
Fungal biosynthesis of gold nanoparticles: mechanism and scale up
por: Kitching, Michael, et al.
Publicado: (2015) -
Silver nanoparticle technology in orthopaedic infections
por: Jeyaraman, Madhan, et al.
Publicado: (2023) -
COVID-19 vaccine-associated myocarditis
por: Morgan, Michael C, et al.
Publicado: (2022) -
Vaccination in the elderly
por: Derhovanessian, Evelyna, et al.
Publicado: (2012)